BMS' Breyanzi and Amgen’s Blincyto will now be available to patients in England with certain types of blood cancer.
“The main issue is that at-home devices tend to be underpowered,” said Dr. Tito Vasquez, assistant professor of plastic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback